Journal of Nuclear Cardiology

, Volume 11, Issue 4, pp 440–449 | Cite as

Potential utility of rubidium 82 pet quantification in patients with 3-vessel coronary artery disease

  • R. Parkash
  • R. A. deKemp
  • T. D. Ruddy
  • A. Kitsikis
  • R. Hart
  • L. Beauschene
  • Kathryn Williams
  • R. A. Davies
  • M. Labinaz
  • R. S. B. Beanlands
Article
Received:
Accepted:

Abstract

Background

Standard perfusion imaging may underestimate the extent of disease in 3-vessel coronary atherosclerosis. This study determined whether positron emission tomography quantification of perfusion reserve by use of rubidium 82 net retention defined a greater extent of disease than the standard approach in patients with 3-vessel disease.

Methods and Results

Rb-82 net retention was quantified as an estimation of absolute perfusion at rest and with dipyridamole stress by use of dynamic positron emission tomography imaging. The percent of abnormal myocardial sectors, as compared with a normal database, for a standard and quantification approach was determined. Twenty-three patients were evaluated. Defect sizes were larger in patients with 3-vessel disease (n-13) by use of quantification methods: 44%-18% of the myocardial sectors were abnormal by use of the standard approach versus 69%-24% of sectors when measured by quantification of the stress-rest perfusion difference (P-.008). In patients with single-vessel disease (n-10), defect sizes were smaller with quantification methods.

Conclusions

Quantification of Rb-82 net retention to measure the stress-rest perfusion difference in the myocardium defined a greater extent of disease than the standard approach in this group of patients with triple-vessel disease. More accurate measurement of the extent of coronary artery disease could facilitate better risk stratification and identify more high-risk patients in whom aggressive intervention is required.

Key Words

Positron emission tomography myocardial flow coronary artery disease 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Demer LL, Gould LK, Goldstein RA, et al. Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients. Circulation 1989;79:825–35.PubMedGoogle Scholar
  2. 2.
    Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990;31:1899- 905.PubMedGoogle Scholar
  3. 3.
    Stewart RE, Schwaiger M, Molina E, et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for the detection of coronary artery disease. Am J Cardiol 1991;67:1303–10.PubMedCrossRefGoogle Scholar
  4. 4.
    Gould KL, Goldstein RA, Mullani NA, et al. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using a generatorproduced rubidium-82. J Am Coll Cardiol 1986;7:775–89.PubMedGoogle Scholar
  5. 5.
    Schelbert HR, Wisenberg G, Phelps ME, et al. Noninvasive assessment of coronary stenosis by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in man with intravenous N-13 ammonia and positron computed tomography. Am J Cardiol 1982;49:1197–207.PubMedCrossRefGoogle Scholar
  6. 6.
    Yonekura Y, Tamaki N, Senda M, et al. Detection of coronary artery disease with N-13-ammonia and high resolution positron emission computed tomography. Am Heart J 1987;113:645–54.PubMedCrossRefGoogle Scholar
  7. 7.
    Berman DS, Kiat HS, Friedman JD, et al. Separate acquisitions rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455–64.PubMedGoogle Scholar
  8. 8.
    Zaret BL, Rigo P, Wackers FJ, et al. The Tetrofosmine International Trial Study Group: myocardial perfusion imaging with 99mTc-tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Circulation 1995;91:313–99.PubMedGoogle Scholar
  9. 9.
    Gould KL, Kirkeeide R, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. Part I. Relative and absolute coronary flow reserve during changing aortic pressure. Part II. Determination from arteriographic stenosis dimensions under standardized conditions. J Am Coll Cardiol 1990;15:459–74.PubMedGoogle Scholar
  10. 10.
    Hutchins GD, Schwaiger M, Rosenspire KC, et al. Noninvasive quantification of regional myocardial blood flow in the human heart using N-13 ammonia and dynamic positron emission tomography imaging. J Am Coll Cardiol 1990;15:1032–42.PubMedGoogle Scholar
  11. 11.
    deKemp RA, Ruddy TD, Hewitt T, et al. Detection of serial changes in absolute myocardial perfusion with Rb-82 PET. J Nucl Med 2000;41:1426–35.PubMedGoogle Scholar
  12. 12.
    Lin JW, Sciacca RR, Chou RL, Laine AF, Bergmann SR. Quantification of myocardial perfusion in human subjects using 82Rb and wavelet-based noise reduction. J Nucl Med 2001;42:201–8.PubMedGoogle Scholar
  13. 13.
    Nienaber CA, Ratib O, Gambhir SS, et al. A quantitative index of regional blood flow in canine myocardium derived noninvasively with N-13 ammonia and dynamic positron emission tomography. J Am Coll Cardiol 1991;17:260–9.PubMedGoogle Scholar
  14. 14.
    Kuhle WG, Porenta G, Huang SC, et al. Quantification of regional myocardial blood flow using N-13 ammonia and reoriented dynamic positron emission tomographic imaging. Circulation 1993; 86:1004–17.Google Scholar
  15. 15.
    Choi Y, Huang SC, Hawkins RA, et al. A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. J Nucl Med 1993;34:488–97.PubMedGoogle Scholar
  16. 16.
    Scott NS, LeMay MR, deKemp RA, et al. Evaluation of myocardial perfusion using rubidium-82 positron emission tomography after myocardial infarction in patients receiving primary stent or thrombolytic therapy. Am J Cardiol 2001;88:886–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Gewirtz H, Skopicki HA, Abraham SA, et al. Quantitative PET measurements of regional myocardial blood flow: observations in humans with ischemic heart disease. Cardiology 1997;88:62–70.PubMedCrossRefGoogle Scholar
  18. 18.
    Herrero P, Markham J, Shelton ME, Weinheimer CJ, Bergmann SR. Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model. Circulation 1990;82:1377–86.PubMedGoogle Scholar
  19. 19.
    deKemp RA, Nahmias C. Automated determination of the left ventricular long axis in cardiac positron tomography. Physiol Meas 1996;17:95–108.PubMedCrossRefGoogle Scholar
  20. 20.
    Diamond G, Forrester J. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979;300:1350–8.PubMedGoogle Scholar
  21. 21.
    Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med 1996;37:1701–12.PubMedGoogle Scholar
  22. 22.
    Beanlands RS. Positron emission tomography in cardiovascular disease. Can J Cardiol 1996;12:875–83.PubMedGoogle Scholar
  23. 23.
    Gould KL. Clinical cardiac positron emission tomography: state of the art. Circulation 1991;84(Suppl I):I-22-I-36.Google Scholar
  24. 24.
    Camici PG, Gropler RJ, Jones T, et al. The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases. Eur Heart J 1996;17:25–34.PubMedGoogle Scholar
  25. 25.
    Uren NG, Melin JA, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Di Carli M, Czernin J, Hoh CK, et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 1995;91:1944–51.PubMedGoogle Scholar
  27. 27.
    Herrero P, Markham J, Shelton ME, Bergmann SR. Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography. Circ Res 1992;70:496–507.PubMedGoogle Scholar
  28. 28.
    Tamaki N, Ruddy TD, deKemp RA, Beanlands R. Myocardial perfusion. In: Wahl R, editor. Principles and practice of positron emission tomography. Philadelphia: Lippincott Williams and Wilkins; 2002. p. 320–33Google Scholar
  29. 29.
    Bergmann SR, Fox KAA, Rand AL, et al. Quantification of regional myocardial blood flow in vivo with H2 15O. Circulation 1984;70:724–33.PubMedGoogle Scholar
  30. 30.
    Iida H, Kanno I, Takahashi A, et al. Measurement of absolute myocardial blood flow with H2 15O and dynamic positron emission tomography: strategy for quantification in relation to the partialvolume effect. Circulation 1988;78:104–15.PubMedGoogle Scholar
  31. 31.
    Ahn JY, Lee DS, Lee JS, et al. Quantification of regional myocardial blood flow using dynamic H2(15)O PET and factor analysis. J Nucl Med 2001;42:782–7.PubMedGoogle Scholar
  32. 32.
    Beanlands R, Muzik O, Melon P, et al. Noninvasive quantification of regional myocardial flow reserve in stenosed and angiographically normal vessels of patients with coronary atherosclerosis. J Am Coll Cardiol 1995;26:1465–75.PubMedCrossRefGoogle Scholar
  33. 33.
    Kaufmann PA, Gnecchi-Ruscone T, Yap JT, Rimoldi O, Camici PG. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurement with 15O-labeled water and PET. J Nucl Med 1999;40:1848–56.PubMedGoogle Scholar
  34. 34.
    Sawada S, Muzik O, Beanlands R, et al. Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen-13-ammonia labeled positron emission tomography. J Nucl Cardiol 1995;2:413–22.PubMedCrossRefGoogle Scholar
  35. 35.
    Nagamachi S, Czernin J, Kim AS, et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 1996;37:1626–31.PubMedGoogle Scholar
  36. 36.
    Muzik O, Duvernoy C, Beanlands RSB, et al. Assessment of the diagnostic performance of quantitative flow measurements in normals and patents with angiographically documented CAD using [N-13]ammonia and PET. J Am Coll Cardiol 1998;31:534–40.PubMedCrossRefGoogle Scholar
  37. 37.
    Gould KL. Quantification of coronary artery stenosis in vivo. Circ Res 1985;57:341–53.PubMedGoogle Scholar
  38. 38.
    Choi Y, Huang SC, Hawkins RA, et al. Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. J Nucl Med 1999;40:1045–55.PubMedGoogle Scholar
  39. 39.
    Gill JB, Ruddy TD, Newell JB, et al. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 1987;317:1486–9.PubMedGoogle Scholar
  40. 40.
    Weiss AT, Berman DS, Lew AS, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: a marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Pitkanen O, Raitakari O, Niinikoski H, et al. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol 1996;28:1705–11.PubMedCrossRefGoogle Scholar
  42. 42.
    Yokoyama I, Momomura S, Ohtake T, et al. Reduced myocardial flow reserve in non-insulin dependent diabetes mellitus. J Am Coll Cardiol 1997;30:1472–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Yokoyama I, Ohtake T, Momomura S, et al. Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM. Diabetes 1998;47:119–24.PubMedCrossRefGoogle Scholar
  44. 44.
    Czernin J, Sun K, Brunken R, et al. Effect of acute and long-term smoking on myocardial blood flow and flow reserve. Circulation 1995;91:2891–7.PubMedGoogle Scholar
  45. 45.
    Laine H, Raitakari OT, Niinikoski H, et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 1998;32:147–53.PubMedCrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2004

Authors and Affiliations

  • R. Parkash
    • 1
  • R. A. deKemp
    • 1
  • T. D. Ruddy
    • 1
  • A. Kitsikis
    • 1
  • R. Hart
    • 1
  • L. Beauschene
    • 1
  • Kathryn Williams
    • 1
  • R. A. Davies
    • 1
  • M. Labinaz
    • 1
  • R. S. B. Beanlands
    • 1
  1. 1.Cardiac PET Center, Division of Cardiology, Department of MedicineUniversity of Ottawa Heart InstituteOttawaCanada

Personalised recommendations